| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |